Trilogy Capital’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Trilogy Capital’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,700	Closed	-$75K	–	126
2019 Q3	$75K	Hold	17,700	–	–	0.01%	112
2019 Q2	$54K	Hold	17,700	–	–	0.01%	115
2019 Q1	$31K	Hold	17,700	–	–	﹤0.01%	124
2018 Q4	$15K	Hold	17,700	–	–	﹤0.01%	131
2018 Q3	$25K	Hold	17,700	–	–	﹤0.01%	256
2018 Q2	$15K	Hold	17,700	–	–	﹤0.01%	275
2018 Q1	$24K	Hold	17,700	–	–	﹤0.01%	212
2017 Q4	$18K	Buy	+17,700	New	+$20K	﹤0.01%	117

Trilogy Capital's CVRS Position: Q4 2019 in Review

Trilogy Capital sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 17,700 shares — an estimated $75K sold.

Trilogy Capital first reported a position in CVRS in Q4 2017 and held it in 8 quarters. The position peaked at $75K in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

Trilogy Capital reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
Trilogy Capital sold 17,700 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $75K.
Trilogy Capital first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q4 2017 and held it in 8 quarters.
Trilogy Capital's CORINDUS VASCULAR ROBOTICS, INC position peaked at $75K in Q3 2019.
0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Trilogy Capital's 13F filing for Q4 2019, filed 10 Jan 2020.